|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| A61K 38/07 | |||
| A61P 35/00 |
| (11) | Number of the document | 3347054 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16765958.0 |
| Date of filing the European patent application | 2016-09-09 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/071336 |
| Date | 2016-09-09 |
| (87) | Number | WO 2017/042352 |
| Date | 2017-03-16 |
| (30) | Number | Date | Country code |
| 201562217320 P | 2015-09-11 | US |
| (72) |
LISBY, Steen, DK
WHITING, Nancy Cherry, US
|
| (73) |
Genmab A/S,
Kalvebod Brygge 43, 1560 Copenhagen V,
DK
|
| (54) | DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES |
| DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES |